This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Zenas BioPharma Securities Class Action
Business class action

Zenas BioPharma Securities Class Action

Analysis based on 19 articles · First reported Apr 21, 2025 · Last updated May 02, 2025

Sentiment
-20
Attention
2
Articles
19
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The class action lawsuit against Zenas BioPharma could lead to significant financial penalties and reputational damage for the company, potentially impacting its stock price (ZBIO). For investors who purchased Zenas BioPharma securities, this event represents an opportunity to recover losses through the legal process initiated by Levi & Korsinsky.

Biotechnology Legal Services
Event Summary

Zenas BioPharma is facing a class action securities lawsuit initiated by Levi & Korsinsky. The lawsuit alleges that Zenas BioPharma made false and misleading statements in its September 2024 initial public offering (IPO) registration statement and prospectus. Specifically, the complaint claims that Zenas BioPharma materially overstated the duration it could fund its operations using existing cash and expected IPO proceeds. Investors who acquired Zenas BioPharma securities during the relevant period are encouraged to join the lawsuit, with a deadline of June 16, 2025, to request appointment as lead plaintiff. Joseph E. Levi and Levi & Korsinsky are the attorneys from Levi & Korsinsky handling the case.

Key Actions
100 Levi & Korsinsky notifies investors of lawsuit Zenas BioPharma
Entities Involved
priv
Zenas BioPharma
Zenas BioPharma is facing a class action securities lawsuit for allegedly making false and misleading statements regarding its financial sustainability during its September 2024 IPO.
Importance 100.0 Sentiment -50.0
priv
Levi & Korsinsky
Levi & Korsinsky is the law firm initiating and representing investors in the class action securities lawsuit against Zenas BioPharma.
Importance 80.0 Sentiment 20.0
per
Joseph E. Levi
Joseph E. Levi is an attorney at Levi & Korsinsky, involved in the class action lawsuit against Zenas BioPharma.
Importance 30.0 Sentiment 10.0
Relationships
Levi & Korsinsky related ↔ Joseph E. Levi
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.